Valgen Medtech Co., Ltd.
PrivateLast Round
Series B
May 6, 2021
Est. Valuation
$1.43B
Total Funding Raised
$158M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Valgen Medtech Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series B round in May 2021.
Valgen Medtech Co., Ltd. is a medical device company that specializes in the research, development, and manufacturing of interventional treatment solutions for structural heart diseases, including mitral and tricuspid valve repair systems.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valgen Medtech Co., Ltd. Comparables
Compare Valgen Medtech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Hanyu Medical Technology | 93% | |
| Jenscare Scientific Co Ltd | 89% | |
| Peijia Medical | 86% |
For institutional investors. Book with your work email.
Valgen Medtech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 6, 2021 | ||||
| Series A | Apr 1, 2019 |
For institutional investors. Book with your work email.
Valgen Medtech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCP Capital | Series B |
| BioTrack Capital | Series A |
| Lake Bleu Capital | Series B |
| Qiming Venture Partners | Series A, Series B |
| HongShan Capital Group (HSG) | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2026
Grew 56% QoQ, from 9 to 14 employees.
- Jul 21, 2026
Grew 33% QoQ, from 9 to 12 employees.
For institutional investors. Book with your work email.
Valgen Medtech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Valgen Medtech Co., Ltd.'s valuation, stock price, and market status.
Is Valgen Medtech Co., Ltd. a public or private company?
Valgen Medtech Co., Ltd. is a private company.
What is the current stock price of Valgen Medtech Co., Ltd.?
Valgen Medtech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Valgen Medtech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Valgen Medtech Co., Ltd. worth (valuation)?
Valgen Medtech Co., Ltd.'s valuation is estimated at $1.4B based on funding round data.
Can I buy Valgen Medtech Co., Ltd. stock?
Valgen Medtech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Valgen Medtech Co., Ltd.'s last funding round?
Valgen Medtech Co., Ltd.'s most recent funding round was Series B on May 6, 2021.
Who are the main investors in Valgen Medtech Co., Ltd.?
Key investors in Valgen Medtech Co., Ltd. include DCP Capital, HongShan Capital Group (HSG).
Will Valgen Medtech Co., Ltd. IPO soon?
No public IPO plans have been announced for Valgen Medtech Co., Ltd..
How can I track Valgen Medtech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Valgen Medtech Co., Ltd.'s shares on secondary markets.